Clinical Trial Update: Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial is assessing whether terazosin alters ATP levels in people with amyotrophic lateral sclerosis, with the study currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Terazosin (terazosin)

Snippet

Sponsor: University of Iowa | Conditions: Amyotrophic Lateral Sclerosis, Adenosine Triphosphate Activities | EARLY_Phase 1 | Status: NOT_YET_RECRUITING